KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Study reveals potential target for precision colorectal cancer treatment - Redox Medicine Society
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
Les biomarqueurs prédictifs dans le cancer colorectal
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
:quality(90)/ "Roche | Cancer du côlon : les principales mutations")
Roche | Cancer du côlon : les principales mutations
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | Annals of Surgical Oncology
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
Frequencies of KRAS mutations measured using methods with different... | Download Scientific Diagram
APMG Colon Molecular Pathways
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer | PNAS
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Colorectal Cancer
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
Kras in metastatic colorectal cancer
